Global Pharmaceutical Amino Acids Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Pharmaceutical Amino Acids Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Amino acids (AAs) are a group of organic molecules in which each is comprised of a basic amino group (-NH2), an acidic carboxyl group (-COOH), and an organic R group (or side chain) that is unique to each amino acid. Amino acids are building blocks of proteins, as well as the intermediates in metabolism. The amino and the carboxyl groups of amino acids react to form a covalent amide linkage, called a peptide bond. This feature of amino acids allows them to polymerize to form proteins as well as peptides, which generally have shorter amino acid chain length. Amino acids can be classified into three groupsessential amino acids, non-essential amino acids and conditional amino acids. Amino acids are commonly used as supplements in cell culture media and in metabolism research.
Pharmaceutical Amino Acids report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Pharmaceutical Amino Acids market is projected to reach US$ 1569.3 million in 2034, increasing from US$ 1326.1 million in 2022, with the CAGR of 2.5% during the period of 2024 to 2034. Demand from Active Pharmaceuticals Ingredients (APIs) and Pharmaceutical Intermediates are the major drivers for the industry.
The main manufacturers of Pharmaceutical Amino Acids are Ajinomoto, Evonik and Meihua Holding Group, etc. The top five manufacturers account for about 70% of the share. The USMCA is the largest market with about 35% share, followed by Europe and Asia with more than 25% share. Glycine is the largest segment, with a roughly 30% share. Active Pharmaceuticals Ingredients (APIs) is the largest application with a share of around 60%.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Pharmaceutical Amino Acids market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Ajinomoto
Evonik
Kyowa Hakko
AMINO
Meihua Holding Group
Tianjin Tianyao
Jingjing
Wuxi Jinghai
Jiahe Biotech
Hubei Bafeng
Grand Hoyo
Yichang Sanxia Proudin
Shine Star
Segment by Type
Glycine
L-Threonine
L-Alanine
L-Leucine
L-Cysteine
L-Arginine
L-Valine
L-Isoleucine
Active Pharmaceuticals Ingredients (APIs)
Pharmaceutical Intermediates
Cell Culture Media Ingredients
Pharmaceutical Excipients
Medical Food
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Pharmaceutical Amino Acids market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Pharmaceutical Amino Acids, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Pharmaceutical Amino Acids industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Pharmaceutical Amino Acids in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Pharmaceutical Amino Acids introduction, etc. Pharmaceutical Amino Acids Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Pharmaceutical Amino Acids market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Pharmaceutical Amino Acids report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Pharmaceutical Amino Acids market is projected to reach US$ 1569.3 million in 2034, increasing from US$ 1326.1 million in 2022, with the CAGR of 2.5% during the period of 2024 to 2034. Demand from Active Pharmaceuticals Ingredients (APIs) and Pharmaceutical Intermediates are the major drivers for the industry.
The main manufacturers of Pharmaceutical Amino Acids are Ajinomoto, Evonik and Meihua Holding Group, etc. The top five manufacturers account for about 70% of the share. The USMCA is the largest market with about 35% share, followed by Europe and Asia with more than 25% share. Glycine is the largest segment, with a roughly 30% share. Active Pharmaceuticals Ingredients (APIs) is the largest application with a share of around 60%.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Pharmaceutical Amino Acids market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Ajinomoto
Evonik
Kyowa Hakko
AMINO
Meihua Holding Group
Tianjin Tianyao
Jingjing
Wuxi Jinghai
Jiahe Biotech
Hubei Bafeng
Grand Hoyo
Yichang Sanxia Proudin
Shine Star
Segment by Type
Glycine
L-Threonine
L-Alanine
L-Leucine
L-Cysteine
L-Arginine
L-Valine
L-Isoleucine
Segment by Application
Active Pharmaceuticals Ingredients (APIs)
Pharmaceutical Intermediates
Cell Culture Media Ingredients
Pharmaceutical Excipients
Medical Food
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Pharmaceutical Amino Acids market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Pharmaceutical Amino Acids, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Pharmaceutical Amino Acids industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Pharmaceutical Amino Acids in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Pharmaceutical Amino Acids introduction, etc. Pharmaceutical Amino Acids Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Pharmaceutical Amino Acids market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.